arrow
Return

Groupware development support with technology patterns

delete2006-07-01
delete19
PRE
AI
S
Stephan Lukosch *
DOI:10.1016/j.ijhcs.2006.02.006delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Groupware development support should educate developers on how to design groupware applications and foster the reuse of proven solutions. Additionally, it should foster communication between developers and end-users, since they need a common language and understanding of the problem space. Groupware frameworks provide solutions for the development of groupware applications by means of building blocks. They have become a prominent means to support. developers, but from our experience frameworks have properties that complicate their usage and do not sufficiently support groupware developers. We argue for a pattern approach to support the technical aspects of groupware development. Patterns describe solutions to recurring issues in groupware development. They serve as educational and communicative vehicle for reaching the above goals. In this article, we provide a pattern language focusing on technical issues during groupware development. Experiences when using the language in an educational setting and a product development setting have shown that the patterns are a supportive means for the proposed goals. (c) 2006 Elsevier Ltd. All rights reserved.
Keywords:
groupware development
design patterns
education of groupware developers
Oregon Software Development Process (OSDP)
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

I
International Journal of Human-Computer Studies
IF:
5.1
Papers:
2.9K
Citations:
8.9K

Organization

No organization information available
Cited Papers

Cited Papers

errShare
errSave
errShare
errSave
Delphipanel on Antimicrobial Stewardship and Management of Clinical Syndromes in Thoracic Organ Transplants and Mechanical Circulatory Device Recipients
err2022-04-01
err0
PREAI
errM. Luong; F.P. Silveira; O. Morrissey; L. Danziger-Isakov; E. Verschuuren; C.R. Wolfe; D. Hadjiliadis; D. Chambers; J.K. Patel; G. Dellgren; M. So; G.M. Verleden; E.A. Blumberg; R. Vos; M. Perch; A.M. Holm; N. Müller; C. Chaparro; S. Husain
errShare
errSave
The role of SHIP in cytokine-induced signaling
err2024-09-16
err0
PREAI
errJ. Kalesnikoff; L. M. Sly; M. R. Hughes; T. Büchse; M. J. Rauh; L.-P. Cao; V. Lam; A. Mui; M. Huber; G. Krystal
errShare
errSave
The framework life span
err1997-10-01
err18
errOAAI
errBrugali, D; Menga, G; Aarsten, A
errShare
errSave
Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Preliminary results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc) for the non-L sarcoma cohort.
err2021-05-20
err0
PREAI
errDaniel Pink; Dimosthenis Andreou; Anne Flörcken; Alexander Golf; Stephan Richter; Torsten Kessler; Martin Kortüm; Christian Andreas Schmidt; Bernd Kasper; Eva Wardelmann; Jeanette Bahr; Daniel Wilhelm Mueller; Disorn Sookthai; Salah-Eddin Al-Batran; Peter Reichardt
errShare
errSave
researcher View more